Lido Advisors
DXCM icon

Lido Advisors’s DexCom DXCM Stock Holding History

Lido Advisors’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.09M Buy
33,324
+10,125
+44% +$705K 0.01% 691
2025
Q4 		$1.56M Sell
23,199
-67
-0.3% -$4.33K ﹤0.01% 808
2025
Q3 		$1.57M Buy
23,266
+4,865
+26% +$385K ﹤0.01% 765
2025
Q2 		$1.61M Sell
18,401
-59
-0.3% -$4.63K 0.01% 662
2025
Q1 		$1.26M Buy
18,460
+3,365
+22% +$275K 0.01% 675
2024
Q4 		$1.17M Sell
15,095
-2,599
-15% -$192K 0.01% 701
2024
Q3 		$1.19M Buy
17,694
+165
+0.9% +$13.5K 0.01% 638
2024
Q2 		$1.99M Sell
17,529
-43,690
-71% -$5.52M 0.01% 450
2024
Q1 		$8.49M Buy
61,219
+3,351
+6% +$421K 0.05% 197
2023
Q4 		$7.18M Buy
57,868
+1,570
+3% +$160K 0.05% 215
2023
Q3 		$5.25M Buy
56,298
+52,748
+1,486% +$5.95M 0.04% 231
2023
Q2 		$456K Buy
3,550
+528
+17% +$63.9K ﹤0.01% 777
2023
Q1 		$351K Sell
3,022
-89
-3% -$9.96K ﹤0.01% 824
2022
Q4 		$352K Sell
3,111
-211
-6% -$23.2K ﹤0.01% 748
2022
Q3 		$267K Sell
3,322
-1,476
-31% -$125K ﹤0.01% 794
2022
Q2 		$357K Sell
4,798
-958
-17% -$87.4K ﹤0.01% 654
2022
Q1 		$736K Buy
5,756
+532
+10% +$58.2K 0.01% 474
2021
Q4 		$701K Buy
5,224
+196
+4% +$28.2K 0.01% 505
2021
Q3 		$687K Buy
5,028
+632
+14% +$79.7K 0.01% 485
2021
Q2 		$469K Buy
4,396
+72
+2% +$6.91K 0.01% 565
2021
Q1 		$389K Sell
4,324
-348
-7% -$32.7K 0.01% 569
2020
Q4 		$432K Buy
4,672
+116
+3% +$10.4K 0.01% 517
2020
Q3 		$470K Sell
4,556
-1,412
-24% -$148K 0.01% 395
2020
Q2 		$605K Sell
5,968
-36
-0.6% -$3.22K 0.02% 314
2020
Q1 		$404K Sell
6,004
-40
-0.7% -$2.49K 0.02% 368
2019
Q4 		$331K Buy
+6,044
New +$287K 0.01% 473
2019
Q2 		– Sell
-9,648
Closed -$287K – 551
2019
Q1 		$287K Sell
9,648
-264
-3% -$9.28K 0.02% 401
2018
Q4 		$296K Buy
+9,912
New +$314K 0.03% 313

Other funds holding DXCM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Lido Advisors's DXCM Position: Q1 2026 in Review

Lido Advisors increased its DexCom (DXCM) stake by 44% in Q1 2026, buying an estimated $705K and bringing the position to 33,324 shares worth $2.09M. The position accounts for 0.01% of the portfolio, ranked #691.

Lido Advisors first reported a position in DXCM in Q4 2018 and has held it in 28 quarters since. The position peaked at $8.49M in Q1 2024. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Lido Advisors held 33,324 shares of DexCom worth $2.09M as of Q1 2026.
  • Lido Advisors bought 10,125 DexCom shares in Q1 2026, an estimated $705K.
  • DexCom made up 0.01% of Lido Advisors's portfolio in Q1 2026, its #691 holding.
  • Lido Advisors first reported a position in DexCom in Q4 2018 and has held it in 28 quarters since.
  • Lido Advisors's DexCom position peaked at $8.49M in Q1 2024.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Lido Advisors's 13F filing for Q1 2026, filed 13 May 2026.